Literature DB >> 15936109

Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).

Akihiro Matsumoto1, Yasuhisa Matsukawa, Takehiko Suzuki, Hiroyuki Yoshino.   

Abstract

For the multi-reservoir type microspheres composed of poly(dl-lactide-co-glycolide) (PLGA) and poly(dl-lactide) (PLA), the influence of the drug-holding layer and the non-drug-holding layer on drug release profiles was studied. The microspheres with the blend of PLGA and PLA were prepared by the W/O type emulsion-solvent evaporation technique, and cisplatin was used as a model drug. The degree of water uptake and the erosion of each polymer were evaluated to clarify the mechanism of drug release for multi-reservoir type microspheres. The blending of PLA and PLGA provided two types of microspheres in terms of the drug distribution in a microsphere, depending on the ratio of the blend: the microspheres with the drug-holding layer covered by the non-drug layer and the microspheres with the drug on the outer region. The drug release in the early period was governed by the pattern of drug distribution. The drug release rate at a steady state was governed by the erosion of the drug-holding layer. The results of present study indicate that drug release from multi-reservoir type microspheres involves the following process: (a) rapid release of the drug near the surface of microspheres, (b) formation of micropores in the non-drug-holding layer by hydration and erosion, (c) degradation of the drug-holding layer, and (d) diffusion of the drug through micropores.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936109     DOI: 10.1016/j.jconrel.2005.03.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications.

Authors:  Eric M Bachelder; Tristan T Beaudette; Kyle E Broaders; Jesse Dashe; Jean M J Fréchet
Journal:  J Am Chem Soc       Date:  2008-07-17       Impact factor: 15.419

2.  Evaluation of bone matrix and demineralized bone matrix incorporated PLGA matrices for bone repair.

Authors:  A Champa Jayasuriya; Nabil A Ebraheim
Journal:  J Mater Sci Mater Med       Date:  2009-03-29       Impact factor: 3.896

3.  Microparticles produced by the hydrogel template method for sustained drug delivery.

Authors:  Ying Lu; Michael Sturek; Kinam Park
Journal:  Int J Pharm       Date:  2013-12-11       Impact factor: 5.875

4.  Fabrication of cisplatin-loaded poly(lactide-co-glycolide) composite microspheres for osteosarcoma treatment.

Authors:  Yan Li; Sierin Lim; Chui Ping Ooi
Journal:  Pharm Res       Date:  2011-10-07       Impact factor: 4.200

5.  Effect of polymer blending on the release of ganciclovir from PLGA microspheres.

Authors:  Sridhar Duvvuri; Kumar Gaurav Janoria; Ashim K Mitra
Journal:  Pharm Res       Date:  2006-12-06       Impact factor: 4.200

6.  Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy.

Authors:  Fiorenza Rancan; Dimitrios Papakostas; Sabrina Hadam; Steffen Hackbarth; Thierry Delair; Charlotte Primard; Bernard Verrier; Wolfram Sterry; Ulrike Blume-Peytavi; Annika Vogt
Journal:  Pharm Res       Date:  2009-06-17       Impact factor: 4.200

7.  Smart Microneedles with Porous Polymer Coatings for pH-Responsive Drug Delivery.

Authors:  Asad Ullah; Haroon Khan; Hye Jin Choi; Gyu Man Kim
Journal:  Polymers (Basel)       Date:  2019-11-07       Impact factor: 4.329

8.  How bulk fluid renewal can affect in vitro drug release from PLGA implants: Importance of the experimental set-up.

Authors:  C Bassand; L Benabed; J Freitag; J Verin; F Siepmann; J Siepmann
Journal:  Int J Pharm X       Date:  2022-09-19

9.  NMR cryoporometry characterisation studies of the relation between drug release profile and pore structural evolution of polymeric nanoparticles.

Authors:  Navin Gopinathan; Bin Yang; John P Lowe; Karen J Edler; Sean P Rigby
Journal:  Int J Pharm       Date:  2014-04-12       Impact factor: 5.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.